Acetylcholine receptor autoantibody secretion by thymocytes: Relationship to myasthenia gravis

Neurology

Volumn 49, Issue 2, 1997, Pages 562-567

  Yoshikawa, Hiroaki ^a   Lennon, Vanda A ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CHOLINERGIC RECEPTOR; CORTICOSTEROID;

ANIMAL CELL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ANTIGEN SPECIFICITY; ARTICLE; COMBINED IMMUNODEFICIENCY; FEMALE; HISTOPATHOLOGY; MALE; MOUSE; MYASTHENIA GRAVIS; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; SERODIAGNOSIS; THYMECTOMY; THYMOCYTE;

EID: 0030766642     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.49.2.562     Document Type: Article

References (25)

1. Lennon VA, Lambert EH. Myasthenia gravis induced by monoclonal antibodies to acetylcholine receptors. Nature 1980;285:238-240.
2. Marx A, O'Connor R, Geuder KI, et al. Characterization of a protein with an acetylcholine receptor epitope from myasthenia gravis-associated thymomas. Lah Invest 1990;62:279-286.
3. Nelson S, Conti-Tronconi BM. Adult thymus expresses an embryonic nicotinic acetylcholine receptor-like protein. J Neuroimmunol 1990;29:81-92.
4. Hara Y, Ueno S, Uemichi T, et al. Neoplastic epithelial cells express α-subunit of muscle nicotinic acetylcholine receptor in thymomas from patients with myasthenia gravis. FEBS Lett 1991;279:137-140.
5. Wheatley LM, Urso D, Tumas K, Maltzman J, Loh E, Levinson AI. Molecular evidence for the expression of nicotinic acetylcholine receptor α-chain in mouse thymus. J Immunol 1992;148:3105-3109.
6. Marx A, Kirchner T, Greiner A, Müller-Hermelink HK, Schalke B, Osborn M. Neurofilament epitopes in thymoma and antiaxonal autoantibodies in myasthenia gravis. Lancet 1992;339:707-708.
7. Mittag T, Kornfeld P, Tormay A, Woo C. Detection of anti-acetylcholine receptor factors in serum and thymus from patients with myasthenia gravis. N Engl J Med 1976;294:691-694.
8. Vincent A, Scadding GK, Thomas HC, Newsom-Davis J. In-vitro synthesis of anti-acetylcholine receptor antibody by thymic lymphocytes in myasthenia gravis. Lancet 1978;1:305-307.
9. Scadding GK, Vincent A, Newsom-Davis J, Henry K. Acetylcholine receptor antibody synthesis by thymic lymphocytes: correlation with thymic histology. Neurology 1981;31:935-943.
10. Shinomiya N, Yata J. B and T cell involvement in anti-acetylcholine receptor antibody formation in myasthenia gravis. Clin Exp Immunol 1981;46:277-285.
11. Willcox HN, Newsom-Davis J, Calder LR. Greatly increased autoantibody production in myasthenia gravis by thymocyte suspensions prepared with proteolytic enzymes. Clin Exp Immunol 1983;54:378-386.
12. Fujii Y, Monden Y, Nakahara K, Hashimoto J, Kawashima Y. Antibody to acetylcholine receptor in myasthenia gravis: production by lymphocytes from thymus or thymoma. Neurology 1984;34:1182-1186.
13. Willcox HN, Newsom-Davis J, Calder LR. Cell types required for anti-acetylcholine receptor antibody synthesis by cultured thymocytes and blood lymphocytes in myasthenia gravis. Clin Exp Immunol 1984;58:97-106.
14. Fujii Y, Hashimoto J, Monden Y, Ito T, Nakahara K, Kawashima Y. Specific activation of lymphocytes against acetylcholine receptor in the thymus in myasthenia gravis. J Immunol 1986;136:887-891.
15. Lisak RP, Levinson AI, Zweiman B, Kornstein MJ. In vitro synthesis of IgG and antibodies to AChR by peripheral and thymic lymphocytes. Ann NY Acad Sci 1987;505:39-49.
16. Lennon VA. Serological profile of myasthenia gravis and distinction from the Lambert-Eaton myasthenic syndrome. Neurology 1997; 48 (suppl 5):S23-S27.
17. Drachman DB. Myasthenia gravis. N Engl J Med 1994;330:1797-1810.
18. Griesmann GE, Lennon VA. Detection of autoantibodies in myasthenia gravis and Lambert-Eaton myasthenic syndrome. Chapter 123. In: Rose NR, Conway De Macario E, Folds JD, et al., eds. ASM Manual of Clinical and Laboratory Immunology. 5th ed. Washington, DC: ASM Press, 1997:983-988.
19. Osserman KE, Genkins G. Studies in myasthenia gravis: review of a twenty-year experience in over 1200 patients. Mt Sinai J Med 1971;38:497-537.
20. Sano M, Lennon VA. Enzyme immunoassay of anti-human acetylcholine receptor autoantibodies in patients with myasthenia gravis reveals correlation with striational autoantibodies. Neurology 1993;43:573-578.
21. Andrews PI, Massey JM, Sanders DB. Acetylcholine receptor antibodies in juvenile myasthenia gravis. Neurology 1993;43:977-982.
22. Schönbeck S, Padberg F, Hohlfeld R, Wekerle H. Transplantation of thymic autoimmune environment to severe combined immunodeficiency mice. A new model of myasthenia gravis. J Clin Invest 1992;90:245-250.
23. Martino G, Dupont BL, Wollmann RL, et al. The human-severe combined immunodeficiency myasthenic mouse model. A new approach for the study of myasthenia gravis. Ann Neurol 1993;34:48-56.
24. Lennon VA, Griesmann GE. Evidence against acetylcholine receptor having a main immunogenic region as target for autoantibodies in myasthenia gravis. Neurology 1989;39:1069-1076.
25. Williams CL, Lennon VA. Thymic B lymphocyte clones from patients with myasthenia gravis secrete monoclonal striational autoantibodies reacting with myosin, a actinin, or actin. J Exp Med 1986;164:1043-1059.